About 100 reports

Type 2 Diabetes (Metabolic Disorder) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes - Drugs In Development, 2021, provides an overview of the Type 2 Diabetes (Metabolic Disorders) pipeline landscape.Type 2 diabetes is a chronic...

  • Type 2 Diabetes
  • Endocrine Disease
  • World

Global Type 2 Diabetes Market 2021-2025 The analyst has been monitoring the type 2 diabetes market and it is poised to grow by $ 29.91 billion during 2021-2025, progressing at a CAGR of about 10% during the forecast period. Our report on the type 2 diabetes market provides a holistic analysis, market size and forecast,...

  • Type 2 Diabetes
  • World
  • Diabetes Prevalence
  • Overweight Prevalence

Gastric Inhibitory Polypeptide Receptor - Drugs In Development, 2021 Summary Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) pipeline Target constitutes close to 26 molecules. Out of which approximately 23 molecules are developed by companies...

  • Type 2 Diabetes
  • Pharmaceutical
  • Diabetes
  • Therapy
  • Drug Development
  • Dementia
  • Type 1 Diabetes
  • Biotechnology
  • World
  • Diabetes Prevalence
  • Energy Consumption

Type 2 Diabetes - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes - Pipeline Review, H2 2020, provides an overview of the Type 2 Diabetes (Metabolic Disorders) pipeline landscape. Type 2 diabetes is a chronic condition and is...

  • Type 2 Diabetes
  • Endocrine Disease
  • World

Glucose Dependent Insulinotropic Receptor - Drugs In Development, 2021 Summary Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) - G protein-coupled receptor 119 also known as GPR119 is a G protein-coupled receptor that is encoded by the GPR119 gene. GPR119 is expressed...

  • Type 2 Diabetes
  • Pharmaceutical
  • World
  • Japan
  • Drug Approval
  • Smoking Prevalence

Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Drugs in Development, 2021 Summary Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) pipeline Target constitutes close to 13 molecules. Out of which approximately 11 molecules are developed by companies and remaining...

  • Therapy
  • Type 2 Diabetes
  • Diabetes
  • World
  • Medicine Use

Free Fatty Acid Receptor 1 - Drugs In Development, 2021 Summary According to the recently published report ’Free Fatty Acid Receptor 1 - Drugs In Development, 2021’; Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) pipeline Target constitutes close to 18 molecules. Out...

  • Pharmaceutical
  • Type 2 Diabetes
  • World
  • Drug Approval
  • Diabetes Prevalence

Glucokinase - Pipeline Review, H2 2020 Summary Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) pipeline Target constitutes close to 14 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the universities/institutes. The latest report Glucokinase...

  • Therapy
  • Type 2 Diabetes
  • Diabetes
  • Drug Development
  • World
  • Diabetes Prevalence
  • Medicine Use

Type 2 Diabetes - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes – Pipeline Review, H1 2020, provides an overview of the Type 2 Diabetes (Metabolic Disorders) pipeline landscape. Type 2 diabetes is a chronic condition...

  • Type 2 Diabetes
  • Endocrine Disease
  • World

Type 2 Diabetes: Epidemiology Forecast to 2028 Summary Type 2 diabetes (T2D), formerly known as non-insulin-dependent diabetes mellitus or adult-onset diabetes mellitus, is a chronic disorder of glucose equilibrium that results from the body’s inability to make use of available insulin along with...

  • Type 2 Diabetes
  • World
  • Diabetes Prevalence
  • Overweight Prevalence

Free Fatty Acid Receptor 1 - Pipeline Review, H2 2020 Summary Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) - Free fatty acid receptor 1 (FFA1), also known as GPR40, is a class A G-protein coupled receptor that is encoded by the FFAR1 gene. It is strongly expressed...

  • Type 2 Diabetes
  • World
  • Drug Approval
  • Pharmaceutical Exports

Glucose Dependent Insulinotropic Receptor - Pipeline Review, H2 2020 Summary Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) pipeline Target constitutes close to 8 molecules. Out of which approximately 7 molecules are developed by companies and remaining by...

  • Type 2 Diabetes
  • World
  • Japan
  • Smoking Prevalence

Gastric Inhibitory Polypeptide Receptor - Pipeline Review, H2 2020 Summary Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) pipeline Target constitutes close to 15 molecules. Out of which approximately 12 molecules are developed by companies...

  • Type 2 Diabetes
  • Drug Development
  • Therapy
  • Dementia
  • Pharmaceutical
  • World
  • Energy Consumption

Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma...

  • Diabetes
  • Pharmaceutical
  • Therapy
  • Type 2 Diabetes
  • World
  • Northern Europe
  • Diabetes Prevalence
  • Health Provider Density

Free Fatty Acid Receptor 1 - Pipeline Review, H1 2020 Summary Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) pipeline Target constitutes close to 16 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the universities/institutes....

  • Type 2 Diabetes
  • World
  • Drug Approval
  • Pharmaceutical Exports

Gastric Inhibitory Polypeptide Receptor - Pipeline Review, H1 2020 Summary Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) - Glucose-dependent insulinotropic polypeptide receptor (GIPR) is a transmembrane protein in humans which is encoded...

  • Type 2 Diabetes
  • Drug Development
  • Therapy
  • Dementia
  • Pharmaceutical
  • World
  • Energy Consumption
  • Diabetes Prevalence

Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) pipeline Target constitutes close...

  • Cancer
  • Pharmaceutical
  • Therapy
  • Oncology
  • Drug Development
  • Ophthalmology
  • Eye Disease
  • Type 2 Diabetes
  • World

Glucose Dependent Insulinotropic Receptor - Pipeline Review, H1 2020 Summary According to the recently published report ’Glucose Dependent Insulinotropic Receptor - Pipeline Review, H1 2020’; Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) pipeline Target constitutes...

  • Type 2 Diabetes
  • Pharmaceutical
  • World
  • Japan
  • Smoking Prevalence
  • Lead Export

Free Fatty Acid Receptor 4 - Pipeline Review, H1 2020 Summary Free Fatty Acid Receptor 4 (G Protein Coupled Receptor 120 or G Protein Coupled Receptor 129 or G Protein Coupled Receptor GT01 or Omega 3 Fatty Acid Receptor 1 or G Protein Coupled Receptor PGR4 or GPR120 or GPR129 or FFAR4) - Free...

  • Type 2 Diabetes
  • World

“Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2022” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Glucagon-Like Peptide 1 Receptor Agonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment...

  • Therapy
  • Type 2 Diabetes
  • China
  • World

Heparanase - Pipeline Review, H2 2020 Summary Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) pipeline Target constitutes close to 12 molecules. Out of which approximately 10 molecules are developed by companies and remaining by the universities/institutes. The latest report...

  • Therapy
  • Drug Development
  • Oncology
  • Type 2 Diabetes
  • World

Tyrosine Protein Phosphatase Non Receptor Type 1 - Pipeline Review, H2 2019 Summary Tyrosine Protein Phosphatase Non Receptor Type 1 (Protein Tyrosine Phosphatase 1B or Protein Tyrosine Phosphatase Placental or PTP1B or PTPN1 or EC 3.1.3.48) - Tyrosine-protein phosphatase non-receptor type 1 also...

  • Type 2 Diabetes
  • World
  • Food Consumption

Free Fatty Acid Receptor 4 - Pipeline Review, H2 2019 Summary Free Fatty Acid Receptor 4 (G Protein Coupled Receptor 120 or G Protein Coupled Receptor 129 or G Protein Coupled Receptor GT01 or Omega 3 Fatty Acid Receptor 1 or G Protein Coupled Receptor PGR4 or GPR120 or GPR129 or FFAR4) - Free Fatty...

  • Type 2 Diabetes
  • World

Glucokinase - Pipeline Review, H1 2020 Summary Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) pipeline Target constitutes close to 14 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the universities/institutes. The latest report...

  • Type 2 Diabetes
  • Therapy
  • World
  • Diabetes Prevalence
  • Medicine Use

The global chromium market reached a value of US$ 14.37 Billion in 2021. Looking forward, the analyst expects the market to reach a value of US$ 17.33 Billion by 2027, exhibiting a CAGR of 3.10% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence...

  • HIV AIDS
  • Auto Parts
  • Diabetes
  • Pharmaceutical
  • Type 2 Diabetes
  • Fuel Trade
  • Road Infrastructure
  • Powertrain
  • Dietary Supplement
  • Light Vehicle
  • Stainless Steel
  • World

Diabetic Foot Ulcers (Metabolic Disorder) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Foot Ulcers - Drugs In Development, 2021, provides an overview of the Diabetic Foot Ulcers (Metabolic Disorders) pipeline landscape.Diabetic foot...

  • Type 2 Diabetes
  • Drug Development
  • United States
  • South Africa
  • Drug Approval
  • Medical Technology Density

Diabetic Retinopathy - Epidemiology Forecast to 2029 Summary Diabetic retinopathy is a sight-threatening microvascular eye complication of type 1 and type 2 diabetes, and is a leading cause of preventable visual disability and blindness in working-age adults throughout the world (Rubino et al.,...

  • Type 2 Diabetes
  • World
  • Diabetes Prevalence
  • Hospital Occupancy Rate

The Global Diabetic Retinopathy Market size is expected to reach $7.7 billion by 2027, rising at a market growth of 11.3% CAGR during the forecast period. Diabetic retinopathy is a critical medical disorder that affects the eyes as a result of diabetes or inefficient insulin level in the blood of the patient. Impairment to blood vessels...

  • Type 2 Diabetes
  • World
  • Drug Approval
  • Diabetes Prevalence

Diabetic Nephropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Nephropathy - Drugs In Development, 2022, provides an overview of the Diabetic Nephropathy (Metabolic...

  • Type 2 Diabetes
  • Prescription Drug Sales
  • Health Provider Density

Diabetic Foot Ulcers - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Foot Ulcers - Pipeline Review, H2 2020, provides an overview of the Diabetic Foot Ulcers (Metabolic Disorders) pipeline landscape. Diabetic foot ulcers are sores...

  • Type 2 Diabetes
  • World
  • Drug Approval
  • Employment Income